CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells

Journal of Virology

Volumn 75, Issue 8, 2001, Pages 3779-3790

  Singer, I I ^a   Scott, S ^a   Kawka, D W ^a   Chin, J ^a   Daugherty, B L ^a   DeMartino, J A ^a   DiSalvo, J ^a   Gould, S L ^a   Lineberger, J E ^a   Malkowitz, L ^a   Miller, M D ^a   Mitnaul, L ^a   Siciliano, S J ^a   Staruch, M J ^a   Williams, H R ^a   Zweerink, H J ^a   Springer, M S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; IMMUNOELECTRON MICROSCOPY; MACROPHAGE; MICROVILLUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD4; CELL LINE; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GOLGI APPARATUS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MACROPHAGES; MEMBRANE MICRODOMAINS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, IMMUNOELECTRON; MICROVILLI; RABBITS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; SECRETORY VESICLES; T-LYMPHOCYTES; THERMODYNAMICS;

EID: 0035082676     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.8.3779-3790.2001     Document Type: Article

References (64)

1. An alternate method utilizing small quantities of ligand for affinity purification of monospecific antibodies
2. The B-oligomer of pertussis toxin deactivates CC chemokine ŕeceptor 5 and blocks entry of M-tropic HIV-1 strains
3. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
4. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
5. Human chemokines: An update
6. HIV and SIV gp120 binding does not predict coreceptor function
7. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow
8. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein
9. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
10. Quantitation of L-selectin distribution on human leukocyte microvilli by immunogold labeling and electron microscopy
11. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals
12. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-I isolates
13. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
14. Identification of a major co-receptor for primary isolates of HIV-1
15. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
16. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events
17. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
18. + cells is mediated by the chemokine receptor CC-CKR-5
19. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts
20. Detection and spatial distribution of the beta 2 integrin (Mac-1) and L-selecting (LECAM-1) adherence receptors on human neutrophils by high-resolution field emission SEM
21. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
22. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
23. A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation
24. Dimerization of cell surface receptors in signal transduction
25. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins
26. Cell migration - Movin' on
27. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
28. Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells
29. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates
30. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene
31. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1
32. ++ signaling: A new view of an old problem
33. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines
34. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
35. A trimeric structural domain of the HIV-1 transmembrane glycoprotein
36. Chemokines - Chemotactic cytokines that mediate inflammation
37. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors
38. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy
39. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants
40. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
41. Bidirectional transport by distinct populations of COPI-coated vesicles
42. Chemokine receptors: Gateways to inflammation and infection
43. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β, and MIP-1α
44. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
45. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2
46. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
47. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
48. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
49. Epitopes of the CD4 antigen and HIV infection
50. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding
51. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1
52. The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy
53. Focal adhesion motility revealed in stationary fibroblasts
54. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
55. Application of cryoultramicrotomy to immunocytochemistry
56. Use of poly(vinylpyrrolidone) and poly(vinyl alcohol) for cryoultramicrotomy
57. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
58. HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4
59. Switching signals on or off by receptor dimerization
60. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
61. The antigenic structure of the HIV gp120 envelope glycoprotein
62. Constitutive cell surface association between CD4 and CCR5
63. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk